β-Aminoarteether maleate
Modify Date: 2025-09-21 19:32:23
β-Aminoarteether maleate structure
|
Common Name | β-Aminoarteether maleate | ||
|---|---|---|---|---|
| CAS Number | 133162-25-1 | Molecular Weight | 443.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H33NO9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of β-Aminoarteether maleateβ-Aminoarteether maleate (SM934) is an Artemisinin derivative with orally active. β-Aminoarteether maleate can be used for inflammation and autoimmune disease research, such as lupus diseases[1]. |
| Name | β-Aminoarteether maleate |
|---|
| Description | β-Aminoarteether maleate (SM934) is an Artemisinin derivative with orally active. β-Aminoarteether maleate can be used for inflammation and autoimmune disease research, such as lupus diseases[1]. |
|---|---|
| Related Catalog | |
| In Vitro | β-Aminoarteether (SM934;10 µM; 24 hours) treatment directly enhances IL-10 production and suppresses IL-12/23p40 production in primary peritoneal macrophages with IFN-γ stimulation[1]. In vitro, β-Aminoarteether (SM934) could suppress the Th1 and Th17 polarization, but exerted no influence on Treg differentiation[1]. |
| In Vivo | β-Aminoarteether (SM934; 1-10 mg/kg; oral administration; daliy; for 3 months) treatment significantly delays the progression of glomerulonephritis and increases the survival rate of NZB/W F1 mice. β-Aminoarteether treatment promots the IL-10 production of macrophages from NZB/W F1 mice[1]. Animal Model: Female NZB/W F1 mice (Six and half months old)[1] Dosage: 1 mg/kg, 3 mg/kg, and 10 mg/kg Administration: Oral administration; daliy; for 3 months Result: Significantly delayed the progression of glomerulonephritis and increased the survival rate of NZB/W F1 mice. |
| References |
| Molecular Formula | C21H33NO9 |
|---|---|
| Molecular Weight | 443.49 |